ロンザ株式会社 CDMO事業
[細胞・遺伝子治療] TxCell Names Lonza as Its CAR-Treg Cellular Product Manufacturer
登録日：2018/06/04
更新日：2019/10/18
・Master Service Agreement signed between Lonza Pharma & Biotech and TxCell for the manufacture of TxCell’s HLA-A2 CAR-Treg cellular product (TX200)
・Lonza Pharma & Biotech to manufacture clinical batches of TxCell’s HLA-A2 CAR-Treg cellular product from its production site in Geleen (NL)
（リンク先より全文をご覧頂けます/英語）
